Avelox (Moxifloxacin, BAY12-8039)

DRUG13 trials

Sponsors

Bayer

Conditions

Acute Bacterial SinusitisAnti-Infective AgentsBronchitis, ChronicChronic BronchitisElectrocardiographyInfection, Intra-abdominalInfectious DiseasesLung Abscess

Phase 1

Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

CompletedNCT01014247

BayerElectrocardiography, QTc Evaluation

Start: 2009-11-30End: 2010-06-30Updated: 2013-06-03

Phase 3

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

CompletedNCT00431678

Start: 2004-01-31End: 2005-07-31Updated: 2014-12-17

Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

CompletedNCT00473460

BayerBronchitis, Chronic, Lung Diseases

Start: 2004-10-31End: 2007-01-31Updated: 2014-10-28

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

CompletedNCT00683865

BayerPelvic Inflammatory Disease

Start: 2003-04-30End: 2004-10-31Updated: 2014-10-15

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

CompletedNCT00717561

Start: 2008-02-29End: 2009-06-30Updated: 2014-11-04

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

CompletedNCT00769171

BayerInfection, Intra-abdominal

Start: 2005-10-31End: 2007-01-31Updated: 2014-12-18

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

CompletedNCT00828971

BayerInfectious Diseases

Start: 2008-11-30End: 2009-10-31Updated: 2014-12-08

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

CompletedNCT01045902

BayerLung Abscess, Pneumonia, Aspiration

Start: 2001-02-28End: 2005-01-31Updated: 2010-01-11

Phase 4

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

CompletedNCT00656747

BayerChronic Bronchitis

Start: 2008-03-31End: 2010-12-31Updated: 2014-12-01

Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

CompletedNCT00665327

Start: 2002-11-30End: 2004-04-30Updated: 2014-11-18

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

CompletedNCT00668304

BayerMaxillary Sinusitis

Start: 2004-06-30End: 2005-01-31Updated: 2014-12-19

Unknown Phase

Treatment of Patients With Acute Sinusitis

CompletedNCT00930488

BayerAcute Bacterial Sinusitis

Start: 2007-03-31End: 2008-12-31Updated: 2012-11-20

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

CompletedNCT01690533

BayerAnti-Infective Agents

Start: 2008-05-13End: 2013-07-19Updated: 2018-05-21

Related Papers

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.

2015-06-026 citations

Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.

2013-04-231 citations

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

2011-06-297 citations

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

2010-01-28125 citations